The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

1251 AVENUE OF THE AMERICAS, NEW YORK, NY 10020-1104, USA
Tel:
Work +1 212 335 4500
Fax:
Fax +1 212 335 4501
Web:
www.dlapiper.com

John Hillebrecht

Tel:
Work 1 212 335 4590
Email:
DLA Piper LLP (US)

Work Department

Trial and Appellate; Litigation

Position

Partner

Career

John M. Hillebrecht is a veteran trial and appellate lawyer with an extensive background in high-profile cases and over 25 years of experience handling complicated criminal and civil litigation and investigations.

Immediately prior to joining DLA Piper in 2010, John served for 15 years as an Assistant United States Attorney in the Southern District of New York, garnering extensive trial, appellate and supervisory experience.

Education

JD, Stanford Law School; BA, Georgetown University


United States: Dispute resolution

Corporate investigations and white-collar criminal defense

Within: Corporate investigations and white-collar criminal defense

DLA Piper LLP (US)’s nationwide practice is led by Jonathan King in Chicago and the FCPA-focused John Hillebrecht in New York. Hillebrecht represented NASDAQ-listed technology firm Net1 UEPS in an SEC and DOJ FCPA investigation, and parallel South African criminal investigation, into allegations of bribery. A longstanding client, GlaxoSmithKline engages the firm on global government and internal investigation matters, on which Washington DC’s Laura Terrell takes the lead. Also recommended are Philadelphia’s Ilana Eisenstein, Baltimore’s Brett Ingerman and Washington DC’s Matthew Graves.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to